SPARC is down-regulated by DNA methylation and functions as a tumor suppressor in T-cell lymphoma

Jiaqin Yan(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Xiaolong Wu(First Affiliated Hospital of Zhengzhou University), Xudong Zhang(Agricultural Genomics Institute at Shenzhen), Renyin Chen(First Affiliated Hospital of Zhengzhou University), Junhui Zhang(Chongqing University), Xin Li(Hubei University of Medicine), Xinhua Wang(Chinese Academy of Sciences), Ling Li(Sichuan University), Lei Zhang(First Affiliated Hospital of Zhengzhou University), Jingjing Wu(Beijing Tian Tan Hospital), Hui Yu(Beihua University), Wencai Li(First Affiliated Hospital of Zhengzhou University), Xiaorui Fu(First Affiliated Hospital of Zhengzhou University), Yu Chang(Jilin University), Feifei Nan(First Affiliated Hospital of Zhengzhou University), Xiaoyan Feng(Academy of Military Medical Sciences), Zhenchang Sun(First Affiliated Hospital of Zhengzhou University), Zhaoming Li(First Affiliated Hospital of Zhengzhou University)
Experimental Cell Research
December 23, 2017
10.1016/j.yexcr.2017.12.022
Cited by 15

Related Papers

New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk
|Nature Communications|2016|318
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
|Cancer Cell|2018|251
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition
|Acta Diabetologica|2019|183